Category: Press Release

27 Aug 2024; OSLO, Norway; CAPE TOWN, South Africa: Scientists in South Africa will investigate whether synthetic DNA could act as an alternative to traditional plasmid DNA required for mRNA vaccines—potentially

Read more

Merck Inks Deal to Develop mRNA in Africa–Continent Prepares to Become Vaccine Development Independent. Merck KGaA or “Merck Germany” entered into a non-binding Memorandum of Understanding (MoU) with Afrigen Biologics

Bio-Sourcing and Afrigen Biologics (Pty) Ltd partner on groundbreaking #biomanufacturing platform to improve access to biotherapeutics in South Africa. hashtag#Technologytransfer will strengthen South Africa’s pharmaceutical sovereignty and drastically reduce production

. 🔽 Read the full story here: https://lnkd.in/ddvF_eKY & https://lnkd.in/dhUiY9tE… hashtag#Vaccine hashtag#Biologicsforall hashtag#GlobalHealth hashtag#Afrigen hashtag#Univercells

💉

Evaxion Partners With Pharmaceutical Company #Afrigen Biologics to Develop Novel #mRNA Vaccine Against Gonorrhea ➡ Partnership based on a highly protective #vaccine candidate identified by Evaxion Biotech A/S’s EDENTM platform ➡ The collaboration will access mRNA technology

ICGEB and AFRIGEN sign MoU to strengthen partnership for training in vaccine development and technology transfer ⏬⏬⏬ click on the link below for more info! https://lnkd.in/ddvF_eKY #afrigen #pressrelease #Afrigen #ICGEBCapeTown